7.2 Non-tunneled Central Venous Catheters

Key Takeaways

  • Non-tunneled CVCs are short-term central catheters inserted percutaneously into internal jugular, subclavian, or femoral veins, commonly for critical care and acute multi-lumen needs.
  • Use maximal sterile barrier precautions and skin antisepsis at insertion; confirm tip/placement per protocol (often chest radiograph for IJ/subclavian approaches) before full use.
  • Subclavian insertion carries notable pneumothorax risk; femoral sites have historically higher infection risk and mobility/contamination concerns—avoid as first choice without indication.
  • Remove non-tunneled CVCs as soon as they are no longer essential; longer dwell without need drives CLABSI risk.
  • During removal, prevent air embolism with positioning, timed breath-hold/Valsalva as appropriate, occlusive dressing, and controlled technique.
Last updated: August 2026

Non-tunneled CVCs: short-term central workhorses

Non-tunneled central venous catheters (also called percutaneous CVCs, temporary central lines, or acute CVCs) enter the vein near the skin insertion site without a long subcutaneous tunnel or cuff anchoring system. They are the default short-term central devices in ICUs, EDs, and OR/PACU settings when patients need vasopressors, multi-lumen incompatible infusions, central venous pressure monitoring, emergency access, or short courses of central therapy.

Quick Answer: Non-tunneled CVCs are inserted into internal jugular (IJ), subclavian, or femoral veins for short-term central access. Use maximal sterile barriers. Confirm placement (commonly chest x-ray for IJ/subclavian) before relying on the line for full therapy. Subclavian → watch pneumothorax. Femoral → historically higher infection and contamination risk—not first choice without indication. Remove early when not needed. On removal, prevent air embolism (positioning, patient breath technique, occlusive dressing).

Device profile

FeatureNon-tunneled CVC
TunnelNone (skin entry near vein puncture)
CuffNone
Typical settingCritical care, acute hospital
Dwell conceptShort-term (days; remove when indication ends)
LumensOften multi-lumen
Infection risk relativeHigher than established tunneled/implanted devices over time if left in place

They are not intended as months-long outpatient devices the way many tunneled catheters or ports are planned.

Insertion sites compared

SiteAdvantagesKey risks / cautions
Internal jugular (IJ)Ultrasound-friendly; compressible if bleeding; common ICU choiceCarotid puncture risk; patient comfort; dressing challenges with tracheostomy/beards
SubclavianOften comfortable for patient; lower reported infection in some classic literature vs femoralPneumothorax and hemothorax risk; noncompressible site if bleeding; landmark vs US technique issues
FemoralRapid in codes; useful when upper body sites unavailable (trauma, coagulopathy strategies per team)Historically highest infection risk among the three in many series; thrombosis; hygiene/mobility; not preferred long dwell

Exam trap: Choosing femoral as routine first-line “because it’s easy” without clinical indication. Prefer IJ/subclavian strategies consistent with ultrasound competency, coagulopathy, lung pathology, and institutional CLABSI reduction programs unless scenario forces femoral use.

Clinical site selection cues

  • Severe COPD / bullous disease / positive pressure issues: teams may avoid subclavian to reduce pneumothorax risk when alternatives exist
  • Coagulopathy: compressible sites (often IJ or femoral) may be favored over subclavian
  • Code/CPR: femoral or other rapidly accessible sites may be used for speed
  • Chronic kidney disease with future fistula plans: protect upper-extremity veins; coordinate with nephrology regarding subclavian stenosis risk and PICC overuse—device choice is multidisciplinary

Insertion safety: maximal barriers and confirmation

Maximal sterile barrier precautions

Non-tunneled CVC insertion is a high-stakes aseptic procedure:

  1. Hand hygiene
  2. Cap, mask, sterile gown, sterile gloves
  3. Large sterile full-body drape
  4. Skin antisepsis (commonly chlorhexidine-alcohol in adults when not contraindicated) with complete dry time
  5. Ultrasound guidance when available/indicated with sterile probe cover
  6. Assisted checklist/timeout culture (WHO-style or institution CLABSI bundle)

Bundle thinking (aligns with Domain 1B CLABSI content): right indication, right site, barriers, chlorhexidine skin prep, daily review of necessity, and sterile maintenance afterward.

Tip and placement confirmation

For IJ and subclavian approaches, chest radiograph (or fluoroscopy/other approved methods) traditionally confirms:

  • Tip in lower SVC / appropriate central position per protocol
  • No pneumothorax or unexpected catheter path
  • No excessive looping or arterial placement suspicion (arterial placement is a critical never-miss)

Do not infuse vasopressors or hyperosmolar therapies through a newly placed line until confirmation rules are met—unless an extreme emergency protocol explicitly allows provisional use with immediate verification pathway.

Ultrasound confirms venous entry and reduces arterial puncture but does not by itself always replace final tip imaging rules in every policy.

Pneumothorax and mechanical complications

ComplicationMore associated withRecognition
PneumothoraxSubclavian (also possible IJ)Dyspnea, desaturation, unequal breath sounds, chest pain; x-ray findings
Arterial puncture/cannulationAll sitesBright pulsatile blood, waveform if transducer available, hematoma
Hematoma / bleedingCoagulopathy, noncompressible sitesExpanding swelling, hemodynamic change
ArrhythmiaDeep wire/catheter in heartEctopy during insertion
Air embolismOpen hub/wire times, upright patient, hypovolemiaSudden respiratory/CV collapse, millwheel murmur classic teaching
Catheter malpositionAllImaging; ipsilateral neck infusion sensations

If pneumothorax is suspected after subclavian attempt: stop, support oxygenation, urgent clinical/imaging evaluation, prepare for intervention as ordered.

Maintenance and dwell discipline

Non-tunneled lines accumulate infection risk with each day they remain after need ends.

  • Scrub the hub; minimize entries; use needleless connectors per policy
  • Assess site each shift; maintain sterile dressing
  • Flush lumens to maintain patency; label lumens for purpose when helpful
  • Daily necessity review: “Can this come out?” is a CLABSI intervention
  • Do not treat a non-tunneled CVC as a long-term home therapy device without conversion planning (tunneled/port/PICC as appropriate)

Guidewire exchange of infected lines is not a casual substitute for removal when infection source control requires device out—follow infectious disease and policy principles.

Removal technique: air embolism prevention

Removal is a procedure, not an afterthought. Air can enter if venous pressure is low and the tract is open to atmosphere.

High-yield steps (adapt to policy and patient tolerance):

  1. Explain procedure; place patient supine or slight Trendelenburg if tolerated (increases central venous pressure)
  2. Remove dressing; cleanse; prepare occlusive dressing (petroleum-based or designated airtight dressing materials per policy)
  3. Instruct Valsalva, humming, or timed exhalation/breath-hold during the moment of withdrawal when the patient can cooperate—raises intrathoracic pressure
  4. Withdraw catheter smoothly during that phase; immediately apply firm pressure then airtight occlusive dressing
  5. Keep patient flat for a prescribed interval when policy requires; monitor respiratory and cardiovascular status
  6. Inspect catheter tip for intactness; document length if required

Upright removal of a large-bore central line without precautions is a classic exam wrong answer due to air embolism risk.

Selection: when non-tunneled beats other CVADs

Choose non-tunneled CVC when:

  • Need is acute and short
  • Multiple incompatible drips require multi-lumen central access now
  • Hemodynamic monitoring or high-acuity vasopressor support is required
  • Patient is not a candidate for immediate PICC (e.g., severe contractures, urgent OR, unstable for arm procedure) and femoral/IJ/subclavian is the path of least harm

Escalate or convert when therapy becomes weeks-long outpatient needs—plan PICC, tunneled catheter, or port rather than leaving a temporary neck/chest/femoral line indefinitely.

Scenario

An ICU patient on dual vasopressors and TPN for three days has a triple-lumen IJ line placed with barriers and post-procedure chest x-ray confirming tip and no pneumothorax. On day four, vasopressors stop and only peripheral-compatible intermittent meds remain. Best thinking: remove the non-tunneled CVC if no other central indication remains, rather than keep it “for convenience.”

High-yield exam traps

  • Femoral first without indication
  • Skipping maximal barriers because “it’s just a quick stick”
  • Using the line before confirmation when policy requires imaging
  • Ignoring pneumothorax risk after subclavian attempts
  • Leaving temporary lines in for weeks without reassessment
  • Removing a CVC with the patient sitting bolt upright, no breath technique, and a non-occlusive bandage
Test Your Knowledge

Which statement best describes non-tunneled central venous catheters?

A
B
C
D
Test Your Knowledge

Compared with internal jugular or subclavian sites, femoral non-tunneled CVCs are most associated with which concern in classic infection-control teaching?

A
B
C
D
Test Your Knowledge

After subclavian non-tunneled CVC insertion, which complication must be specifically considered along with tip position on imaging?

A
B
C
D
Test Your Knowledge

Which removal practice best reduces air embolism risk for a non-tunneled central venous catheter?

A
B
C
D